Literature DB >> 2218563

Staging of bladder cancer: is the tumor, node, metastasis system adequate?

R R Hall1, G R Prout.   

Abstract

Entities:  

Mesh:

Year:  1990        PMID: 2218563

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  5 in total

1.  The value of tumour spread, grading and growth pattern as morphological predictive parameters in bladder carcinoma. A critical revision of the 1987 TNM classification.

Authors:  J C Angulo; J I Lopez; N Flores; J D Toledo
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

2.  TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.

Authors:  P Sivaramakrishna Rachakonda; Ismail Hosen; Petra J de Verdier; Mahdi Fallah; Barbara Heidenreich; Charlotta Ryk; N Peter Wiklund; Gunnar Steineck; Dirk Schadendorf; Kari Hemminki; Rajiv Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

3.  p53 mutations in urinary bladder cancer.

Authors:  P Berggren; G Steineck; J Adolfsson; J Hansson; O Jansson; P Larsson; B Sandstedt; H Wijkström; K Hemminki
Journal:  Br J Cancer       Date:  2001-06-01       Impact factor: 7.640

4.  Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes.

Authors:  Charlotta Ryk; Lotta Renström Koskela; Tomas Thiel; N Peter Wiklund; Gunnar Steineck; Martin C Schumacher; Petra J de Verdier
Journal:  Redox Biol       Date:  2015-08-10       Impact factor: 11.799

5.  Low interleukin-1alpha messenger RNA levels predict decreased overall survival time of patients with urinary bladder carcinoma.

Authors:  M Seddighzadeh; G Steineck; O Jansson; P Larsson; H Wijkström; J Adolfsson; N Portwood; J Hansson; S Linder
Journal:  Br J Cancer       Date:  2001-02-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.